[1] |
郑莹. 中国乳腺癌患者生活方式指南[J]. 浙江医学, 2017, 39(4):239-242.
|
[2] |
ZHAO C L, SINGH K, BRODSKY A S, et al. Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer[J]. BMC Cancer, 2019, 19(1):1036.
DOI
PMID
|
[3] |
NEELAKANTAN D, ZHOU H, OLIPHANT M U J, et al. EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells[J]. Nat Commun, 2017, 8:15773.
DOI
PMID
|
[4] |
MA X, YAN W, DAI Z, et al. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway[J]. Drug Des Devel Ther, 2016, 10:1419-1441.
|
[5] |
ZHANG Z, YANG C, GAO W, et al. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer[J]. Cancer Lett, 2015, 361(2):240-250.
DOI
PMID
|
[6] |
孙振, 周海红, 郭红云, 等. CARD9蛋白在乳腺癌组织中的表达及其临床意义[J]. 肿瘤, 2017, 37(3):245-254.
|
[7] |
GOLDHIRSCH A, WOOD W C, COATES A S, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011, 22(8):1736-1747.
DOI
PMID
|
[8] |
PRECA B T, BAJDAK K, MOCK K, et al. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer[J]. Oncotarget, 2017, 8(7):11530-11543.
DOI
URL
|
[9] |
李艳娇, 张本斯, 李庄, 等. EphA2在乳腺癌中的表达及其与上皮间质转化的关系[J]. 中国临床解剖学杂志, 2018, 36(3):294-298.
|
[10] |
DANG D K, MAKENA M R, LLONGUERAS J P, et al. A Ca2+-ATPase regulates E-cadherin biogenesis and epithelial-mesenchymal transition in breast cancer cells[J]. Mol Cancer Res, 2019, 17(8):1735-1747.
DOI
URL
|
[11] |
邹颖, 邝紫桥, 陈欣欣, 等. Sam68基因过表达可促进乳腺癌MCF-7细胞发生上皮-间质转化[J]. 肿瘤, 2017, 37(1):12-18.
|
[12] |
DI GENNARO A, DAMIANO V, BRISOTTO G, et al. A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness[J]. Cell Death Differ, 2018, 25(12):2165-2180.
DOI
PMID
|
[13] |
XAVIER P L P, CORDEIRO Y G, ROCHETTI A L, et al. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells[J]. Vet Comp Oncol, 2018, 16(4):596-605.
DOI
PMID
|
[14] |
ZHOU X, MEN X, ZHAO R, et al. MiR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer[J]. Cancer Gene Ther, 2018, 25(3-4):68-76.
DOI
PMID
|
[15] |
罗庆丰, 修穆群, 高文, 等. ZEB2蛋白表达和E-caderin蛋白在鼻咽癌转移中的临床意义[J]. 实用癌症杂志, 2019, 34(5):704-706.
|